Technological Innovation in the Virtual Assistance of Patients With Uncontrolled Arterial Hypertension - Hyper 2
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 100 participants.
Also called NCT05843682
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose health services research
- Phase
- Not applicable
- Enrolled
- 100 participants
- Registry
-
NCT05843682
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Unknown status
Technical summary
Registry record NCT05843682. Randomized; no masking; primary purpose health services research. Start 2022-10-07 (actual); primary completion 2023-08-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Technological Innovation in the Virtual Assistance of Patients With Uncontrolled Arterial Hypertension - Hyper 2
- Acronym
- Hyper2
- Condition
- Essential Hypertension
- Condition
- Metabolic Cardiovascular Syndrome
- Condition
- Heart Disease Risk Factors
- Intervention (Device)
- Using the Avatr App
- Lead sponsor
- University of Sao Paulo General Hospital
- Collaborator
- InCor Heart Institute
Record details
- Record id
cardio:ct-nct05843682- Content hash
300f8e804e39aa9623ab5e3953a7044fdae2236d5a17d56c77c676b5d4faf655